Telomerase activity predicts malignancy in percutaneous image-guided needle biopsy specimens of the abdomen and pelvis

Radiology

Volumn 234, Issue 3, 2005, Pages 941-947

  Kundra, Vikas ^a,c   Krane, Jeffrey F ^b   Nikolaidis, Paul ^a,d   Green, Donnella S ^a   Zou, Kelly H ^a   Tuncali, Kemal ^a   VanSonnenberg, Eric ^a   Silverman, Stuart G ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

ABDOMEN; ABDOMINAL CANCER; ADRENAL BIOPSY; ADULT; AGED; ARTICLE; CANCER CYTODIAGNOSIS; CANCER DIAGNOSIS; CLINICAL TRIAL; CYTOPATHOLOGY; DIAGNOSTIC ACCURACY; DOUBLE BLIND PROCEDURE; ENZYME ACTIVITY; FEMALE; FOLLOW UP; HUMAN; KIDNEY BIOPSY; LIVER BIOPSY; LYMPH NODE BIOPSY; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; PELVIS; PELVIS CANCER; PERCUTANEOUS BIOPSY; PRIORITY JOURNAL; PROSPECTIVE STUDY; VALIDATION PROCESS;

ABDOMINAL NEOPLASMS; ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PELVIC NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RADIOGRAPHY, INTERVENTIONAL; SENSITIVITY AND SPECIFICITY; TELOMERASE;

EID: 13844281617     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2343031701     Document Type: Article

References (41)

1. Grosso LE, Collins BT, Dunphy CH, Ramos RR. Lymphocyte-depleted Hodgkin's disease: diagnostic challenges by fine-needle aspiration. Diagn Cytopathol 1998; 19:66-69.
2. Quinn SF, Sheley RC, Nelson HA, Demlow TA, Wienstein RE, Dunkley BL. The role of percutaneous needle biopsies in the original diagnosis of lymphoma: a prospective evaluation. J Vasc Interv Radiol 1995; 6:947-952.
3. Lopez-Rios F, Perez-Barrios A, Alberti N, Vargas J, Lozano F, de Agustin P. Fine-needle aspiration biopsy of the retroperitoneum: a series of 111 cases not including specific organs. Diagn Cytopathol 2002; 27:85-89.
4. Nemanqani D, Mourad WA. Cytomorphologic features of fine-needle aspiration of liposarcoma. Diagn Cytopathol 1999; 20:67-69.
5. Tillou A, Schwartz MR, Jordan PH Jr. Percutaneous needle biopsy of the pancreas: when should it be performed? World J Surg 1996; 20:283-286.
6. Cruz F, Soffia P, del Rio P, et al. Computed tomography guided fine needle aspiration biopsies. Rev Med Chil 1992; 120:1254-1260.
7. Maitra A, Ashfaq R, Saboorian MH, Lindberg G, Gokaslan ST. The role of fine-needle aspiration biopsy in the primary diagnosis of mesenchymal lesions: a community hospital-based experience. Cancer 2000; 90:178-185.
8. Reddy VB, Gattuso P, Abraham KP, Moncada R, Castelli MJ. Computed tomography-guided fine needle aspiration biopsy of deep-seated lesions: a 4-year experience. Acta Cytol 1991; 35:753-756.
9. Donadi M, Rabassini A, Ciarmiello G, Dal Pozzo A, Bacarini L, Lise F. The echo-guided fine-needle biopsy of thoracic and abdominal masses. Radiol Med (Torino) 1991; 82:604-608.
10. Sheikh M, Sawhney S, Dey P, al-Saeed O, Behbehani A. Deep-seated thoracic and abdominal masses: usefulness of ultrasound and computed tomography guidance in fine needle aspiration cytology diagnosis. Australas Radiol 2000; 44:155-160.
11. Jan GM, Mahajan R. Ultrasound guided percutaneous fine needle aspiration biopsy (FNAB) of intraabdominal and retroperitoneal masses. Indian J Gastroenterol 1989; 8:99-100.
12. Silverman SG, Mueller PR, Pinkney LP, Koenker RM, Seltzer SE. Predictive value of image-guided adrenal biopsy: analysis of results of 101 biopsies. Radiology 1993; 187:715-718.
13. Watson JD. Origin of concatemeric T7 DNA. Nature New Biol 1972; 239:197-201.
14. Olovnikov AM. A theory of marginotomy: the incomplete copying of template margin in enzymatic synthesis of polynucleotides and biological significance of the phenomenon. J Theor Biol 1973; 41:181-190.
15. Greider CW, Blackburn EH. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 1985; 43:405-413.
16. Morin GB. Recognition of chromosome truncation site associated with alpha-thalasesmia by human telomerase. Nature 1991; 353:454-456.
17. Morin GB. The human telomerase terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 1989; 59:521-529.
18. Hiyama K, Hirai Y, Kyoizumi S, et al. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995; 155:3711-3715.
19. Weng NP, Levine BL, June CH, Hodes RJ. Regulated expression of telomerase activity in human T lymphocyte development and activation. J Exp Med 1996; 183:2471-2479.
20. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266:2011-2015.
21. Kyo S, Kanaya T, Ishikawa H, Ueno H, Inoue M. Telomerase activity in gynecological tumors. Clin Cancer Res 1996; 2:2023-2038.
22. Hiyama E, Gollahon L, Kataoka T, et al. Telomerase activity in human breast tumors. J Natl Cancer Inst 1996; 88:116-122.
23. Chadeneau C, Hay K, Hirte HW, Gallinger S, Bacchetti S. Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res 1995; 55:2533-2536.
24. Tahara H, Nakanishi T, Kitamoto M, et al. Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res 1995; 55:2734-2736.
25. Langford LA, Piatyszek MA, Xu R, Schold SC Jr, Shay JW. Telomerase activity in human brain tumors. Lancet 1995; 346:1267-1268.
26. Sommerfeld HJ, Meeker AK, Piatyszek MA, Bova GS, Shay JW, Coffey DS. Telomerase activity: a prevalent marker of malignant human prostate tissue. Cancer Res 1996; 56:218-222.
27. Hiyama K, Hiyama E, Ishioka S, et al. Telomerase activity in small-cell and non-small-cell lung cancer. J Natl Cancer Inst 1995; 87:895-902.
28. Sugino T, Yoshida K, Bolodeoku J, et al. Telomerase activity in human breast cancer and benign breast lesions: diagnostic applications in clinical specimens, including fine needle aspirates. Int J Cancer 1996; 69:301-306.
29. Nakashio R, Kitamoto M, Tahara H, Nakanishi T, Ide T, Kajiyama G. Significance of telomerase activity in the diagnosis of small differentiated hepatocellular carcinoma. Int J Cancer 1997; 74:141-147.
30. Nouso K, Urabe Y, Higashi T, et al. Telomerase as a tool for the differential diagnosis of human hepatocellular carcinoma. Cancer 1996; 78:232-236.
31. Takahashi C, Miyagawa I, Kumano S, Oshimura M. Detection of telomerase activity in prostate cancer by needle biopsy. Eur Urol 1997; 32:494-498.
32. Wright WE, Shay JW, Piatyszek MA. Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acid Res 1995; 23:3794-3795.
33. Bryan TM, Englezou A, Gupta J, Bacchetti S, Reddel RR. Telomerase elongation in immortalized human cells without detectable telomerase activity. EMBO J 1995; 14:4240-4248.
34. Gazelle GS, Haaga JR. Guided percutaneous biopsy of intraabdominal lesions. AJR Am J Roentgenol 1989; 153:929-935.
35. Phillips MD, Silverman SG, Cibas ES, Seltzer SE. Negative predictive value of imaging-guided abdominal biopsy results: cytologic classification and implications for patient management. AJR Am J Roentgenol 1998; 171:693-696.
36. Gothlin JH, Gadeholt G. Percutaneous fine needle biopsy of abdominal and pelvic lesions: passes necessary for secure diagnosis with fluoroscopy and CT-guidance. Eur J Radiol 1986; 6:288-290.
37. Orlando C, Gelmini S, Selli C, Pazzagli M. Telomerase activity in urological malignancy. J Urol 2001; 166:666-673.
38. Poremba C, Shroyer KR, Frost M, et al. Telomerase is a highly sensitive and specific molecular marker in fine-needle aspirates of breast lesions. J Clin Oncol 1999; 17:2020-2026.
39. Tsujimura A, Kawamura N, Ichimura T, Honda K, Ishiko O, Ogita S. Telomerase activity in needle biopsied uterine myoma-like tumors: differential diagnosis between uterine sarcomas and leiomyomas. Int J Oncol 2002; 20:361-365.
40. Hirashima T, Yoshitaka O, Nitta T. Telomerase activity in endoscopically visible lung cancer. Anticancer Res 2001; 21:3685-3689.
41. Bamberger CM, Else T, Bamberger AM, et al. Telomerase activity in benign and malignant adrenal tumors. Exp Clin Endocrinol Diabetes 1999; 107:272-275.